Commentary on: Serum Albumin for Tuberculosis in HIV Infected Patients Eligible for Antiretroviral Therapy

Viroj Wiwanitkit

doi:10.5681/bi.2013.033

Bioimpacts. 2013;3(4): 199-200.
doi: 10.5681/bi.2013.033

PMID: 24455484
PMCID: PMC3892740
Scopus ID: 84893385121

Abstract View: 1773

PDF Download: 944

Commentary

Commentary on: Serum Albumin for Tuberculosis in HIV Infected Patients Eligible for Antiretroviral Therapy

Viroj Wiwanitkit ^1,2,3^*

¹ Hainan Medical University, China
² Faculty of Medicine, University of Nis, Serbia
³ Joseph Ayobabalola University, Nigeria

*Corresponding Author: Email: [email protected]

Abstract

n/a

Keywords: n/a, n/a, n/a

First Name

Last Name

Email Address

Comments

Security code

Generate New Image

Type the code from the image

Abstract View: 1774

years	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2026	19	52	31	41	24	38	33	35	55	26
2025	21	24	11	18	24	10	13	20	28	45	99	19
2024	6	3	7	11	12	9	13	16	12	5	10	6
2023	5	7	5	7	7	6	8	3	9	7	3	3
2022	16	10	11	7	10	16	20	15	11	7	11	4
2021	11	13	13	11	14	13	14	18	5	13	17	15
2020	14	14	11	11	21	14	13	10	18	18	19	14
2019	10	12	10	9	18	11	6	13	13	10	3	9
2018	22	12	22	14	12	6	9	19	12	13	7	16
2017	15	23	23	26	15	26	3					17

PDF Download: 944

years	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2026	10	15	14	12	10	20	20	39	25	20
2025	10	6	4	8	7	4	4	11	16	16	10	13
2024	5		5	5	5	3	4	6	7	2	3	7
2023	11	4	4	4	6	5	4	3	4	5	1	4
2022	13	10	12	3	2	4	2	2	4	4	5	8
2021	4	4	4	6	8	12	11	17	13	7	14	13
2020	7	5	11	8	7	4	3	1	5	2	2	6
2019	11	12	4	7	7	9	10	10	8	9	7	12
2018	7	11	14	11	11	14	16	11	13	12	3	20
2017	4	6	6	8	6	11	3					7